Greater Glasgow and Clyde Medicines

Chloroquine and hydroxychloroquine are not licensed to treat COVID-19 related symptoms or prevent infection. Clinical trials are ongoing to test chloroquine and hydroxychloroquine as an agent in the treatment of COVID-1...

The Adult Therapeutics Handbook content has now been updated. This update includes the publication of two new guidelines related to the COVID pandemic in the following sections.

Dietitians can now add an ‘instruction to administer’ an oral nutritional supplement (ONS) to the Kardex (click

The Adult Therapeutics Handbook content has now been updated.  This update includes; Signposting to relevant information on Coronavirus (COVID-19) from within the

New Adult NHSGGC Guidelines now available on StaffNet

The latest Community Pharmacy Update bulletin can be found here. The special edition 3 can be found

Updates from the MHRA for the fourth quarter of 2019

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Key messages: NACSYS® is the preferred oral mucolytic in NHSGGC and should be considered first line for COPD patients unless otherwise directed by a respiratory consultant. COPD patient...